Vasculoprotective effects of heme oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary dysplasia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 302, Issue 8, 2012, Pages

  Fernandez Gonzalez, Angeles ^a   Alex Mitsialis, S ^a   Liu, Xianlan ^a   Kourembanas, Stella ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Carbon monoxide; Endothelial cells; Vascular leak; Vascular permeability; Vasculogenesis

Indexed keywords

CARBON MONOXIDE; FERRITIN; HEME OXYGENASE 1; LACTOFERRIN; SURFACTANT PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTERY WALL; ARTICLE; BLOOD VESSEL REACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; HEART RIGHT VENTRICLE HYPERTROPHY; HISTOLOGY; HYPEROXIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG DYSPLASIA; LUNG EDEMA; LUNG HEMOSIDEROSIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NEWBORN; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; DISEASE MODELS, ANIMAL; FERRITINS; HEME OXYGENASE-1; HEMOSIDEROSIS; HUMANS; INFANT, NEWBORN; IRON; LACTOFERRIN; LUNG; MICE; MICE, TRANSGENIC; OXYGEN; PULMONARY EDEMA;

EID: 84859741507     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00196.2011     Document Type: Article

References (51)

1. Abman SH. Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease. Adv Exp Med Biol 661: 323-335, 2010.
2. Abman SH, Mourani PM, Sontag M. Bronchopulmonary dysplasia: a genetic disease. Pediatrics 122: 658-659, 2008.
3. Abraham NG, Lavrovsky Y, Schwartzman ML, Stoltz RA, Levere RD, Gerritsen ME, Shibahara S, Kappas A. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci USA 92: 6798-6802, 1995.
4. Actor JK, Hwang SA, Kruzel ML. Lactoferrin as a natural immune modulator. Curr Pharm Des 15: 1956-1973, 2009.
5. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, Kourembanas S. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180: 1122-1130, 2009.
6. Balla J, Balla G, Jeney V, Kakuk G, Jacob HS, Vercellotti GM. Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants. Blood 95: 3442-3450, 2000.
7. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098, 2002.
8. Bhandari V. Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med 15: 223-229, 2010.
9. Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, Soares MP. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappaB to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 277: 17950-17961, 2002.
10. Bry K, Hogmalm A, Backstrom E. Mechanisms of inflammatory lung injury in the neonate: Lessons from a transgenic mouse model of bronchopulmonary dysplasia. Semin Perinatol 34: 211-221, 2010.
11. Dauger S, Ferkdadji L, Saumon G, Vardon G, Peuchmaur M, Gaultier C, Gallego J. Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest 123: 530-538, 2003.
12. Deng H, Mason SN, Auten RL Jr. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 162: 2316-2323, 2000.
13. Dennery PA, Lee CS, Ford BS, Weng YH, Yang G, Rodgers PA. Developmental expression of heme oxygenase in the rat lung. Pediatr Res 53: 42-47, 2003.
14. Fernandez-Gonzalez A, Kourembanas S, Wyatt TA, Mitsialis SA. Mutation of murine adenylate kinase 7 underlies a primary ciliary dyski-nesia phenotype. Am J Respir Cell Mol Biol 40: 305-313, 2009.
15. Fogg S, Agarwal A, Nick HS, Visner GA. Iron regulates hyperoxiadependent human heme oxygenase 1 gene expression in pulmonary endothelial cells. Am J Respir Cell Mol Biol 20: 797-804, 1999.
16. Harju T, Soini Y, Paakko R, Kinnula VL. Up-regulation of heme oxygenase-i in alveolar macrophages of newly diagnosed asthmatics. Respir Med 96: 418-423, 2002.
17. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: Role of bilirubin generated by the enzyme. Circ Res 85: 663-671, 1999.
18. Hayes D Jr, Feola DJ, Murphy BS, Shook LA, and Ballard HO. Pathogenesis of bronchopulmonary dysplasia. Respiration 79: 425-436, 2010.
19. Kelly DA, Hislop AA, Hall SM, Haworth SG. Relationship between structural remodeling and reactivity in pulmonary resistance arteries from hypertensive piglets. Pediatr Res 58: 525-530, 2005.
20. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 367: 1421-1431, 2006.
21. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, Abman SH. Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 289: L529-L535, 2005.
22. Lee JY, Keep RF, He Y, Sagher O, Hua Y, Xi G. Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab 30: 1793-1803, 2010.
23. Lee PJ, Alam J, Sylvester SL, Inamdar N, Otterbein L, Choi AMK. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am J Respir Cell Mol Biol 14: 556-568, 1996.
24. Lee PJ, Alam J, Wiegand GW, Choi AMK. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci USA 93: 10393-10398, 1996.
25. Liang OD, Mitsialis SA, Chang MS, Vergadi E, Lee C, Aslam M, Fernandez-Gonzalez A, Liu X, Baveja R, Kourembanas S. Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension. Stem Cells 29: 99-107, 2011.
26. Maines MD. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997.
27. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 98: 8798-8803, 2001.
28. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 96: 2676-2682, 1995.
29. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272: 32804-32809, 1997.
30. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AMK. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103: 1047-1054, 1999.
31. Otterbein LE, Mantell LL, Choi AMK. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 276: L688-L694, 1999.
32. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, Soares MP. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9: 183-190, 2003.
33. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
34. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94: 10919-10924, 1997.
35. Ryan RM, Ahmed Q, Lakshminrusimha S. Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin Rev Allergy Immunol 34: 174-190, 2008.
36. Ryan TP, Krzesicki RF, Blakeman DP, Chin JE, Griffin RL, Richards IM, Aust SD, Petry TW. Pulmonary ferritin: differential effects of hyperoxic lung injury on subunit mRNA levels. Free Radic Biol Med 22: 901-908, 1997.
37. Ryter SW, Choi AM. Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am J Respir Cell Mol Biol 41: 251-260, 2009.
38. Ryter SW, Morse D, Choi AM. Carbon monoxide: to boldly go where no has gone before. Sci STKE 2004: RE6-RE15, 2004.
39. Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 8: 39-49, 2003.
40. Stanford SJ, Hislop AA, Oltmanns U, Nabel EG, Sang H, Haworth SG, Mitchell JA. Transition from placental to air breathing stimulates haem-oxygenase-1 expression without functional consequence for pulmonary vascular adaptation in pigs and mice. Br J Pharmacol 144: 467-476, 2005.
41. Steinhorn RH. Neonatal pulmonary hypertension. Pediatr Crit Care Med 11: S79-S84, 2010.
42. Stenmark KR, Aldashev AA, Orton EC, Durmowicz AG, Badesch DB, Parks WC, Mecham RP, Voelkel NF, Reeves JT. Cellular adaptation during chronic neonatal hypoxic pulmonary hypertension. Am J Physiol Heart Circ Physiol 261: H097-H104, 1991.
43. Suttner DM, Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J 13: 1800-1809, 1999.
44. Turi JL, Yang F, Garrick MD, Piantadosi CA, Ghio AJ. The iron cycle and oxidative stress in the lung. Free Radic Biol Med 36: 850-857, 2004.
45. Vergadi E, Chang MS, Lee C, Liang OD, Liu X, Fernandez-Gonzalez A, Mitsialis SA, Kourembanas S. Early macrophage recruitment and alternative activation are critical for the later development of hypoxiainduced pulmonary hypertension. Circulation 123: 1986-1995, 2011.
46. Visner GA, Fogg S, Nick HS. Hyperoxia-responsive proteins in rat pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 270: L517-L525, 1996.
47. Vitali SH, Mitsialis SA, Liang OD, Liu X, Fernandez-Gonzalez A, Christou H, Wu X, McGowan FX, Kourembanas S. Divergent cardiopulmonary actions of heme oxygenase enzymatic products in chronic hypoxia. PLos One 4: e5978, 2009.
48. Wang X, Wang Y, Kim HP, Nakahira K, Ryter SW, Choi AM. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem 282: 1718-1726, 2007.
49. Warner BB, Stuart LA, Papes RA, Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol Lung Cell Mol Physiol 275: L110-L117, 1998.
50. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999.
51. Zhuang T, Zhang M, Zhang H, Dennery PA, Lin QS. Disrupted postnatal lung development in heme oxygenase-1 deficient mice. Respir Res 11: 142-151, 2010.